Europol cảnh báo tình trạng làm giả giấy xác nhận âm tính SARS-CoV-2

Ngày 1/2, Cơ quan cảnh sát châu Âu (Europol) cảnh báo về hiện tượng các băng nhóm tội phạm có tổ chức làm giả và bán giấy chứng nhận âm tính với virus SARS-CoV-2 tại các sân bay, đôi khi với giá lên tới 300 euro/tờ.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Hy vọng mới trong điều trị ung thư tuyến tụy

Hy vọng mới trong điều trị ung thư tuyến tụy

Thế giới
(Baothanhhoa.vn) - Một loại thuốc thử nghiệm có tên Daraxonrasib đang mở ra hy vọng mới trong điều trị ung thư tuyến tụy, sau khi kết quả nghiên cứu công bố trên tạp chí y khoa New England Journal of Medicine cho thấy thuốc có thể giúp kéo dài gấp đôi thời gian sống...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh